News

IZERVAY™, is the Second Treatment Approved by the FDA for Geographic Atrophy 

IZERVAY™ reduced the rate of GA progression at the 12-month primary endpoint across two Phase 3 clinical trials. IZERVAY slowed loss of photoreceptors and disease progression as early as six months. Astellas Pharma Inc.  announced on August 5, 2023 that the U.S. Food and Drug Administration (FDA) approved IZERVAY™ (avacincaptad pegol intravitreal solution) for the [Read More]

Loss of Confidence

A Message to the AMD Community from Dan Roberts 1998 I have experienced a symptom of vision loss, and I wonder if anyone else can relate to it. It is not physical, and it is not emotional. This is a much more subtle psychological symptom which seems to lurk in the background and affect nearly [Read More]

Growing Up With Vision Loss

by Sharon Chism I am going to attempt to tell my story of growing up with vision loss. I have no idea if mine is typical for those with a juvenile form of retinal degeneration but I hope that it is helpful, nevertheless. I am the oldest of four children, three of which have what [Read More]